Zika virus particles (red) shown in African green monkey kidney cells. Using blood samples from an individual previously infected with Zika virus, scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have developed an antibody-based Zika virus therapeutic that protected monkeys from infection. Because monoclonal antibodies are generally safe, they believe that this antibody cocktail might be appropriate for uninfected pregnant women, because the antibodies will likely cross the placenta, the researchers hope that administration during pregnancy may protect both the pregnant woman and the foetus from Zika virus. The investigators are hoping to test this concept by pursuing studies in people. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Science Source / NIAID |
Bildgröße: | 4200 px × 3252 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: | - |